PCD included in world leading research study

On 2nd October 2023, Genomics England announced the 200 rare conditions which will be looked as part of its Generation Study, which aims to start in hospitals in late 2023.

The Ciliopathy Alliance are delighted that Primary Ciliary Dyskinesia (PCD), one of many ciliopathies, will be included in this project.  

To find out more about PCD, contact PCD Support UK